AI assistant
Sending…
BIODESIX INC — Director's Dealing 2022
Nov 22, 2022
34472_dirs_2022-11-21_625a83a2-9bc0-46cd-b532-bf8885a1a0d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-11-21
Reporting Person: PATIENCE JOHN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-21 | Common Stock | P | 1739130 | $1.15 | Acquired | 4550483 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 337926 | Direct |
| Common Stock | 2078298 | Indirect |
| Common Stock | 52988 | Indirect |
Footnotes
F1: The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
F2: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
More from BIODESIX INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23